Probiotic tablet may rival mouthwash for fighting gum bacteria in diabetics

NCT ID NCT07489924

First seen Apr 03, 2026 · Last updated Jun 20, 2026 · Updated 10 times

Summary

This study tests whether a probiotic tablet (Lactobacillus reuteri Prodentis) works as well as a chlorhexidine mouthwash for reducing harmful bacteria in people with gum disease and type 2 diabetes. Twenty participants will use either the mouthwash or the probiotic for 30 days. Researchers will measure changes in Porphyromonas gingivalis bacteria levels to see if the probiotic is a good alternative.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • University of Colima

    Colima, 28040, Mexico

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Chlorhexidine mouthwash and probiotic (Lactobacillus reuteri Prodentis) tablet

What this could lead to

If it works, this could show that a simple probiotic tablet is as good as a mouthwash for controlling gum-disease bacteria in people with diabetes.

What could go wrong

This is a very small, early-phase trial with only 20 participants, so results may not apply to everyone. It only measures bacteria levels, not actual gum health or diabetes control.

Conditions

The condition(s) this trial relates to.

diabetes mellitus periodontal disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.